3 Top Diabetes Stocks to Buy in August
DexCom, Tandem Diabetes, and Novo Nordisk have plenty of momentum and growth ahead, making them excellent buys this month.
Novo Nordisk
NVO
NVO
$65.74
-$1.12
-1.7%
Price as of August 14, 2020, 3:04 p.m. EDT
View Interactive NVO Charts
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
Interactive Chart
News & Analysis: Novo Nordisk
The Fool has written over 200 articles on Novo Nordisk.
Novo Nordisk A/S (NVO) Q2 2020 Earnings Call Transcript
NVO earnings call for the period ending June 30, 2020.
Novo Nordisk A/S (NVO) Q1 2020 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2020.
Novo Nordisk A/S (NVO) Q3 2019 Earnings Call Transcript
NVO earnings call for the period ending September 30, 2019.
Novo Nordisk A/S (NVO) Q1 2019 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2019.
Novo Nordisk (NVO) Q4 2018 Earnings Conference Call Transcript
NVO earnings call for the period ending December 31, 2018.
Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript
NVO earnings call for the period ending September 30, 2018.
Novo Nordisk (NVO) Q2 2018 Earnings Conference Call Transcript
NVO earnings call for the period ending June 30, 2018.
Novo Nordisk (NVO) Q1 2018 Earnings Conference Call Transcript
NVO earnings call for the period ending March 31, 2018.
